SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Galena Biopharm...
22 April 2014 - 8:20AM
Brower Piven, A Professional Corporation announces that a class
action lawsuit has been commenced in the United States District
Court for the District of Oregon on behalf of purchasers of Galena
Biopharma, Inc. ("Galena" or the "Company") (Nasdaq:GALE) common
stock during the period between November 6, 2013 and February 14,
2014, inclusive (the "Class Period").
If you have suffered a net loss from investment in Galena common
stock purchased on or after November 6, 2013 and held through the
revelation of negative information during and/or at the end of the
Class Period, and would like to learn more about this lawsuit and
your ability to participate as a lead plaintiff, without cost or
financial obligation, click here:
http://www.browerpiven.com/securitiesfraudcases.html.
You may also request more information by contacting Brower Piven
either by email at hoffman@browerpiven.com or by telephone at (410)
415-6616. Attorneys at Brower Piven together have more than a
century of experience litigating securities and other class action
cases.
No class has yet been certified in the above
action. Members of the Class will be represented by the lead
plaintiff and counsel chosen by the lead plaintiff. If you
wish to choose counsel to represent you and the Class, you must
apply to be appointed lead plaintiff no later than May 5, 2014 and
be selected by the Court. The lead plaintiff will direct the
litigation and participate in important decisions including whether
to accept a settlement and how much of a settlement to accept for
the Class in the action. The lead plaintiff will be selected
from among applicants claiming the largest loss from investment in
Company units during the Class Period.
The complaint accuses the defendants of violations of the
Securities Exchange Act of 1934 by virtue of the defendants'
failure to disclose during the Class Period that to boost its stock
price, the Company engaged in a misleading brand awareness
campaign, including hiring investor relations firm The DreamTeam
Group ("DreamTeam") to publish articles under aliases promoting the
Company's stock without disclosing who paid for them.
According to the complaint, following the February 12, 2014,
publication of an article by Adam Feuerstein on TheStreet.com
disclosing allegations of Galena's misleading brand awareness
campaign and the Company's February 14, 2014 acknowledgment that
the Company had indeed engaged DreamTeam, the value of Galena
shares declined significantly.
If you choose to retain counsel, you may retain Brower Piven
without financial obligation or cost to you, or you may retain
other counsel of your choice. You need take no action at this
time to be a member of the class.
CONTACT: Charles J. Piven
Brower Piven, A Professional Corporation
Stevenson, Maryland
410/415-6616
hoffman@browerpiven.com
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Apr 2024 to May 2024
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From May 2023 to May 2024